Profile
Anton Hoos currently works at Cy Biopharma AG, as Chief Executive Officer and Patient Focused Medicine Development, as Director from 2014.
Dr. Hoos also formerly worked at CSL Behring GmbH, as Vice President and Swedish Orphan Biovitrum AB, as Chief Medical Officer, Head-Medical Affairs, R&D in 2023.
Dr. Hoos received his Masters Business Admin degree from the University of Toronto and doctorate degree from Ludwig-Maximilians-Universität München.
Anton Hoos active positions
| Companies | Position | Start |
|---|---|---|
Patient Focused Medicine Development | Director/Board Member | 2013-12-31 |
Cy Biopharma AG
Cy Biopharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotech platform generating novel psychedelic molecules for breakthrough therapeutics | Chief Executive Officer | - |
Former positions of Anton Hoos
| Companies | Position | End |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 2023-06-18 |
CSL Behring GmbH
CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Corporate Officer/Principal | - |
Training of Anton Hoos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring GmbH
CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Patient Focused Medicine Development | |
Cy Biopharma AG
Cy Biopharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotech platform generating novel psychedelic molecules for breakthrough therapeutics | Commercial Services |
- Stock Market
- Insiders
- Anton Hoos
















